BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30033600)

  • 21. Highly Efficient Enrichment of O-GalNAc Glycopeptides by Using Immobilized Metal Ion Affinity Chromatography.
    Yue X; Qin H; Chen Y; Fang Z; Liu L; Zhu H; Liu X; Zhou J; Tian K; Qiao X; Ye M
    Anal Chem; 2021 Jun; 93(21):7579-7587. PubMed ID: 34009939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of sialylation aberration in N-linked glycopeptides by lectin and tandem labeling (LTL) quantitative proteomics.
    Shetty V; Nickens Z; Shah P; Sinnathamby G; Semmes OJ; Philip R
    Anal Chem; 2010 Nov; 82(22):9201-10. PubMed ID: 20923142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. O-GalNAc incorporation into a cluster acceptor site of three consecutive threonines. Distinct specificity of GalNAc-transferase isoforms.
    Takeuchi H; Kato K; Hassan H; Clausen H; Irimura T
    Eur J Biochem; 2002 Dec; 269(24):6173-83. PubMed ID: 12473113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parallel data acquisition of in-source fragmented glycopeptides to sequence the glycosylation sites of proteins.
    Zhao J; Song E; Zhu R; Mechref Y
    Electrophoresis; 2016 Jun; 37(11):1420-30. PubMed ID: 26957414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic glycoengineering through the mammalian GalNAc salvage pathway.
    Pouilly S; Piller V; Piller F
    FEBS J; 2012 Feb; 279(4):586-98. PubMed ID: 22151230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-specific analysis of the O-glycosylation of bovine fetuin by electron-transfer dissociation mass spectrometry.
    Windwarder M; Altmann F
    J Proteomics; 2014 Aug; 108():258-68. PubMed ID: 24907489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
    Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
    Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
    Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
    Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoenzymatic modular assembly of O-GalNAc glycans for functional glycomics.
    Wang S; Chen C; Gadi MR; Saikam V; Liu D; Zhu H; Bollag R; Liu K; Chen X; Wang F; Wang PG; Ling P; Guan W; Li L
    Nat Commun; 2021 Jun; 12(1):3573. PubMed ID: 34117223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria.
    Wopereis S; Abd Hamid UM; Critchley A; Royle L; Dwek RA; Morava E; Leroy JG; Wilcken B; Lagerwerf AJ; Huijben KM; Lefeber DJ; Rudd PM; Wevers RA
    Biochim Biophys Acta; 2006 Jun; 1762(6):598-607. PubMed ID: 16769205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing sialoglycans on fetal bovine fetuin with azido-sugars using glycosyltransferases.
    Wu ZL; Huang X; Burton AJ; Swift KA
    Glycobiology; 2016 Apr; 26(4):329-34. PubMed ID: 26589574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane.
    Lackman JJ; Goth CK; Halim A; Vakhrushev SY; Clausen H; Petäjä-Repo UE
    Cell Signal; 2018 Jan; 42():184-193. PubMed ID: 29097258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systems analysis of singly and multiply O-glycosylated peptides in the human serum glycoproteome via EThcD and HCD mass spectrometry.
    Zhang Y; Xie X; Zhao X; Tian F; Lv J; Ying W; Qian X
    J Proteomics; 2018 Jan; 170():14-27. PubMed ID: 28970103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early steps in O-linked glycosylation and clustered O-linked glycans of herpes simplex virus type 1 glycoprotein C: effects on glycoprotein properties.
    Biller M; Mårdberg K; Hassan H; Clausen H; Bolmstedt A; Bergström T; Olofsson S
    Glycobiology; 2000 Dec; 10(12):1259-69. PubMed ID: 11159917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From individual proteins to proteomic samples: characterization of O-glycosylation sites in human chorionic gonadotropin and human-plasma proteins.
    Bai X; Li D; Zhu J; Guan Y; Zhang Q; Chi L
    Anal Bioanal Chem; 2015 Mar; 407(7):1857-69. PubMed ID: 25636227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-glycan analysis of recombinant L-Selectin reveals sulfated GalNAc and GalNAc-GalNAc motifs.
    Wedepohl S; Kaup M; Riese SB; Berger M; Dernedde J; Tauber R; Blanchard V
    J Proteome Res; 2010 Jul; 9(7):3403-11. PubMed ID: 20469932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
    Gerken TA
    Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple sugars to complex disease--mucin-type O-glycans in cancer.
    Kudelka MR; Ju T; Heimburg-Molinaro J; Cummings RD
    Adv Cancer Res; 2015; 126():53-135. PubMed ID: 25727146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hypothetical N-glycan charge: a number that characterizes protein glycosylation.
    Hermentin P; Witzel R; Kanzy EJ; Diderrich G; Hoffmann D; Metzner H; Vorlop J; Haupt H
    Glycobiology; 1996 Mar; 6(2):217-30. PubMed ID: 8727793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.